ea0056p1141 | Thyroid cancer | ECE2018
Kalantzi Athanasia
, Papanastasiou Labrini
, Charalabidou Liana
, Lyberopoulos Konstantinos
, Kounadi Theodora
Introduction: Treatment options for progressive metastatic unresectable medullary thyroid carcinoma (MTC) include tyrosine kinase inhibitors (TKIs) or somatostatin analogues (SSA), although the efficacy of the latter is debatable. In such cases, combined treatment of TKIs and SSAs has not previously been reported.Aim: To present a metastatic MTC case successfully treated with a combination of Vandetanib and Lanreotide Autogel.Case ...